Denver—With a revised version of the U.S. Pharmacopeial Convention’s (USP’s) General Chapter <797> set for release for public comment this summer and USP <800> on the horizon in 2019, compliance with both sterile and nonsterile compounding standards are foremost on pharmacists’ minds.
To allay anxiety, Patricia Kienle, RPh, MPA, the director of accreditation and medication at Cardinal Health Innovative Delivery Solutions, and a member of the